News Details

News Details

Hot Pursuit News
As on 18-May-2022  09:22

Zydus Life gains as board to mull buyback
The board will also consider FY22 results and final dividend on 20 May 2022.

Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

On a consolidated basis, the company's net profit fell 5.08% to Rs 500.40 crore on 0.61% increase in revenue from operations to Rs 3,655 crore in Q3 FY22 over Q3 FY21.

Powered by Capital Market - Live News